Lung Cancer Surgery Market Size Report Segmented by Product (Surgical Instruments, Monitoring Systems, Cameras, Endo Surgical Equipment), Application (Thoracotomy, Lobectomy, Minimally Invasive Surgeries), End User (Hospitals, ASCs) Forecast to 2030
The global lung cancer surgery market is set to witness a growth rate of 4% in the next 5 years. Increasing incidence of lung cancer; advancements in surgical techniques, growing geriatric population; growing focus on early cancer detection and treatment; favorable reimbursement policies and integration of advanced imaging and diagnostic tools are some of the key factors driving the lung cancer surgery market. To learn more about the research report, download a sample report.
Report Overview
Lung cancer surgery is a medical procedure aimed at removing cancerous tissue from the lungs. It is primarily used to treat early-stage lung cancer, particularly non-small cell lung cancer (NSCLC), and involves various techniques such as lobectomy (removal of a lung lobe), pneumonectomy (removal of an entire lung), and segmentectomy (removal of part of a lobe). Advanced methods like video-assisted thoracoscopic surgery, and robotic-assisted thoracic surgery offer minimally invasive options, reducing recovery time and complications. Lung cancer surgery is often combined with other treatments, including chemotherapy, radiation, or immunotherapy, to improve patient outcomes and reduce recurrence.
To learn more about this report, download the PDF brochure
Increasing incidence of lung cancer to propel market demand
The increasing incidence of lung cancer indirectly drives the medical aesthetics market by fueling demand for aesthetic procedures to manage physical changes resulting from cancer treatments. According to the International Agency for Research (IARC), Lung cancer was the most frequently diagnosed cancer in 2022, responsible for almost 2.5 million new cases, or 12.4% of all cancers globally. Lung cancer therapies, such as chemotherapy and radiation, often lead to hair loss, skin changes, and facial volume loss, prompting patients to seek cosmetic solutions for improved appearance and self-confidence. Additionally, advancements in minimally invasive aesthetic procedures, like dermal fillers and laser therapies, provide non-surgical options for cancer survivors. The growing focus on post-cancer care and the rising awareness of aesthetic treatments contribute to the expansion of the medical aesthetics market.
Advancements in surgical techniques are driving the market growth
Advancements in surgical techniques are significantly driving the lung cancer surgery market by improving precision, reducing complications, and enhancing patient outcomes. Minimally invasive procedures like video-assisted thoracoscopic surgery and robotic-assisted thoracic surgery enable smaller incisions, faster recovery times, and lower post-operative risks compared to traditional open surgeries. Enhanced imaging technologies, real-time navigation systems, and robotic platforms improve tumor localization and surgical accuracy, leading to better survival rates. Additionally, the adoption of personalized surgical approaches, based on genetic profiling and AI-driven decision-making, is further optimizing treatment, making surgery a preferred option for early-stage lung cancer patients.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global lung cancer surgery market is marked by the presence of established and emerging market players such as Intuitive Surgical, Medtronic, Johnson & Johnson, Olympus Corporation, Siemens Healthineers, Teleflex Incorporated, Accuray Incorporated, AngioDynamics, KARL STORZ SE & Co. KG, and Richard Wolf GmbH; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 - 2030 |
| Growth Rate | 4% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Product, Application, End User |
| Regional Scope |
|
| Key Companies Mapped | Intuitive Surgical, Medtronic, Johnson & Johnson, Olympus Corporation, Siemens Healthineers, Teleflex Incorporated, Accuray Incorporated, AngioDynamics, KARL STORZ SE & Co. KG, and Richard Wolf GmbH among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Lung Cancer Surgery Market Segmentation
This report by Medi-Tech Insights provides the size of the global lung cancer surgery market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, application, end user.
Market Size & Forecast (2023-2030), By Product, USD Million
- Surgical Instruments
- Powered Surgical Instruments
- Hand Instruments
- Monitoring and Visualizing Systems
- Cameras and Video Support
- Endoscopic Trocars with Optical Views
- Endo surgical Equipment
- Others
Market Size & Forecast (2023-2030), By Application, USD Million
- Thoracotomy
- Lobectomy
- Sleeve Resection
- Segmentectomy
- Pneumonectomy
- Minimally Invasive Surgeries
Market Size & Forecast (2023-2030), By End User, USD Million
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the lung cancer surgery market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the lung cancer surgery market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Lung Cancer Surgery Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Increasing incidence of lung cancer
- Advancements in surgical techniques
- Growing geriatric population
- Growing focus on early cancer detection and treatment
- Favourable reimbursement policies
- Integration of advanced imaging and diagnostic tools
- Restraints
- The high cost of lung cancer diagnosis & treatments
- Risk of post-surgical complications
- Increasing adoption of refurbished imaging systems
- Opportunities
- Emerging markets
- Technological innovations in surgical tools
- Development of personalized surgical approaches
- Key Market Trends
- Adoption of minimally invasive surgical techniques
- Integration of advanced imaging technologies
- Unmet Market Needs
- Industry Speaks
- Global Lung Cancer Surgery Market Size & Forecast (2023-2030), By Product, USD Million
- Introduction
- Surgical Instruments
- Powered Surgical Instruments
- Hand Instruments
- Monitoring and Visualizing Systems
- Cameras and Video Support
- Endoscopic Trocars with Optical Views
- Endo Surgical Equipment
- Others
- Global Lung Cancer Surgery Market Size & Forecast (2023-2030), By Application, USD Million
- Introduction
- Thoracotomy
- Lobectomy
- Sleeve Resection
- Segmentectomy
- Pneumonectomy
- Minimally Invasive Surgeries
- Global Lung Cancer Surgery Market Size & Forecast (2023-2030), By End User, USD Million
- Introduction
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Others
- Global Lung Cancer Surgery Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Lung Cancer Surgery Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Canada
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- US
- Europe Lung Cancer Surgery Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Germany
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- France
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Italy
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Spain
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Europe
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- UK
- Asia Pacific (APAC) Lung Cancer Surgery Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Japan
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- India
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- China
- Latin America (LATAM) Lung Cancer Surgery Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Middle East & Africa (MEA) Lung Cancer Surgery Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Intuitive Surgical
- Medtronic
- Johnson & Johnson
- Olympus Corporation
- Siemens Healthineers
- Teleflex Incorporated
- Accuray Incorporated
- AngioDynamics
- KARL STORZ SE & Co. KG
- Richard Wolf GmbH
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Hospitals; Ambulatory Surgical Centers; Thoracic Surgeons and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
